Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
12/1998
12/30/1998CA2292415A1 B7-binding molecules for treating immune diseases
12/29/1998US5854418 Kaposi's sarcoma-associated herpesvirus (KSHV) viral macrophage inflammatory protein-1α II (vMIP-1α II) and uses thereof
12/29/1998US5854416 Streptococcus pneumoniae 37-KDA surface adhesin a protein and nucleic acids coding therefor
12/29/1998US5854398 Kaposi's sarcoma-associated herpesvirus (KSHV) interleukin 6 (IL-6) and uses thereof
12/29/1998US5854395 Cloned borrelia burgdorferi virulence protein
12/29/1998US5854220 Glial mitogenic factors, their preparation and use
12/29/1998US5854206 Compounds and methods for treatment and diagnosis of prostate cancer
12/29/1998US5854204 Aβ peptides that modulate β-amyloid aggregation
12/29/1998US5854069 GD2 anti-idiotypic antibodies and uses thereof
12/29/1998US5854055 Recombinant mycobacteria
12/29/1998US5854051 Parasitic helminth asparaginase proteins, nucleic acid molecules, and uses thereof
12/29/1998US5854044 Recombinant pseudomonas exotoxin with increased activity
12/29/1998US5854037 Recombinant negative strand RNA virus expression systems and vaccines
12/29/1998US5854027 Process for improving the stability of antibodies
12/29/1998US5854024 Hepatitus B vaccine
12/29/1998US5854022 Polynucleotides encoding a CD53-like transmembrane protein
12/29/1998US5854020 TCSTS polynucleotides
12/29/1998US5854016 Creba Isoform
12/29/1998US5854007 Process for producing GM1 specific antibodies
12/29/1998US5853987 Decorin binding protein compositions and methods of use
12/29/1998US5853739 Transmission-blocking vaccine against malaria
12/29/1998US5853737 Method for inducing a CD1-restricted immune response
12/29/1998US5853736 Potentiation of immunogenic response
12/29/1998US5853735 Avirulent anti-rabies vaccine
12/29/1998US5853734 Glycoprotein L and clycoprotein M from kaposi's sarcoma associated herpesvirus, DNA encoding same and uses thereof
12/29/1998US5853724 Dampening of an immunodominant epitope of an antigen for use in plant, animal and human vaccines and immunotherapies
12/29/1998US5853723 Targeting of peg antibody conjugates to islet cells
12/29/1998US5853719 Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA
12/29/1998US5853718 Method of immunization using biologically contained bacterial cells
12/29/1998US5853716 Genetically engineered chimeric viruses for the treatment of diseases associated with viral transactivators
12/29/1998US5853715 Cross-protective equine herpesvirus preparations and method of making and using the same
12/29/1998US5853697 Methods of treating established colitis using antibodies against IL-12
12/29/1998CA2150265C Activation of p53 protein
12/29/1998CA2148689C Treatment of infertility and enhancement of fertilization capacity in mammalian males
12/29/1998CA2129554C Recombinant antibodies specific for tnf-.alpha.
12/29/1998CA2064029C Use of mycobacterium vaccae in the prevention of aids
12/29/1998CA1340289C Interferon-induced human protein in pure form, monoclonal antibodies thereto, and test kits containing these antibodies
12/27/1998CA2234417A1 Human serum glucocorticoid regulated kinase, a target for chronic renal disease
12/26/1998CA2235778A1 Novel glmu
12/26/1998CA2208946A1 Attenuated human immunodeficiency virus vaccine
12/24/1998DE19736198C1 Protease related protein
12/24/1998CA2234418A1 Human afc1
12/23/1998WO1998058080A1 A method for in vitro molecular evolution of protein function
12/23/1998WO1998058059A1 Lag-3 splice variants
12/23/1998WO1998057994A2 Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
12/23/1998WO1998057993A1 Secretory immunoglobulin produced by single cells and methods for making and using same
12/23/1998WO1998057981A2 Chlamydia pneumoniae specific peptides and their use in diagnostic assays
12/23/1998WO1998057672A2 Process for reducing the concentration of viral and molecular pathogens in a biological material
12/23/1998WO1998057661A1 Therapeutic composition and method of treatment
12/23/1998WO1998057660A1 Adjuvant compositions for vaccines
12/23/1998WO1998057659A1 Adjuvant compositions for vaccines
12/23/1998WO1998057658A1 Compact epstein-barr virus replicons
12/23/1998WO1998057657A1 Methods for identifying antibodies and peptides useful in the treatment of septic shock and experimental arthritis and uses thereof
12/23/1998WO1998042868A3 Screening method for proline-rich proteins
12/23/1998WO1998041535A3 Activation of peptides
12/23/1998EP0886142A1 Method for detecting anti-gadii antibody and method for diagnosing cancer using said detection method
12/23/1998EP0885966A2 Novel compouds
12/23/1998EP0885965A2 Histidine kinase polypeptides
12/23/1998EP0885963A2 Compounds comprising polypeptides and polynucleotides of Streptococcus pneumoniae,said polypeptides being related by amino acid sequence homology to SapR from Streptococcus mutans polypeptide
12/23/1998EP0885960A2 G-protein coupled receptor (H7TBA62)
12/23/1998EP0885959A2 Human Wnt-5b protein
12/23/1998EP0885903A2 Nucleic acid encoding streptococcus pheumoniae response regulator
12/23/1998EP0885902A2 Nucleic acid encoding Streptococcus pneumoniae response regulator
12/23/1998EP0885901A2 Nucleic acid encoding Streptococcus pneumoniae response regulator
12/23/1998EP0885614A2 Method of ex vivo immunizing using heterologous intact bispecific and/or trispecific antibodies
12/23/1998EP0885302A1 Recombinant live feline immunodeficiency virus and proviral dna vaccines
12/23/1998EP0885300A1 Transferrin receptor genes of moraxella
12/23/1998EP0885299A1 Wsx receptor and ligands
12/23/1998EP0885297A1 Novel era
12/23/1998EP0885244A1 Peptide immunogens for vaccination against and treatment of allergy
12/23/1998EP0885046A1 Filtration of plasma mixtures using cellulose-based filter aids
12/23/1998EP0885015A2 Modified cytokines for therapeutic use
12/23/1998EP0885013A1 New indications for the use as medicaments of multipotent parapox immunity inducers from attenuated, non-immunogenic pox viruses or parapox viruses
12/23/1998EP0885012A1 Malaria vaccine based upon the addition of a msa1 peptide
12/23/1998EP0885011A2 Vaccines
12/23/1998EP0885002A2 Materials and methods for enhancing cellular internalization
12/23/1998EP0683762B1 Acylfulvene analogues as antitumor agents
12/23/1998EP0663826B1 Amino acids containing parenteral formulations for the treatment of hypotension and related pathologies
12/23/1998EP0648276B1 Monoclonal antibodies to glycoprotein p
12/23/1998EP0647655B1 Synthetic peptides and vaccines against parvovirus
12/23/1998EP0635055B1 Haemophilus somnus immunogenic proteins
12/23/1998EP0607222B1 Dendrimeric polychelants
12/23/1998EP0541629B1 Cloning and expression of a rhoptry associated protein of (p.falciparum)
12/23/1998EP0497972B1 Chemiluminescent 3-(substituted adamant-2'-ylidene) 1,2-dioxetanes
12/23/1998EP0473721B1 Anti-idiotypic antibody which induces an immune response against a glycosphingolipid and use thereof
12/23/1998CN1202934A Delivery of biologically active polypeptides
12/23/1998CN1202932A Therapeutic antiangiogenic compositions and methods
12/23/1998CN1202931A Tumour vaccine and process for the preparation thereof
12/23/1998CN1202905A Parainfluenza virus glycoproteins and vaccines
12/23/1998CN1202829A Method for preserving microoganisms
12/23/1998CN1202824A Combinational therapeutic methods employing nitric oxide scavengers
12/23/1998CN1202822A Use of a THF alpha antagonist for treating neurogenic skin redness
12/23/1998CN1202818A Solubilisation method
12/23/1998CN1202523A Live attenuated bacteria of species actinobacillus pleuropneumoniae
12/23/1998CN1202378A Process for preparing infectious bursal disease virus and avian reovirus using cell lines
12/23/1998CN1041326C Process for preparing CAV nucleic acid series and amino acid series
12/23/1998CA2295440A1 Methods for identifying antibodies and peptides useful in the treatment of septic shock and experimental arthritis and uses thereof
12/23/1998CA2294051A1 Adjuvant compositions for vaccines
12/23/1998CA2293735A1 Lag-3 splice variants
12/23/1998CA2293732A1 Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
1 ... 1551 1552 1553 1554 1555 1556 1557 1558 1559 1560 1561 1562 1563 1564 1565 1566 1567 1568 1569 1570 1571 ... 1823